-2.2 C
London
Saturday, December 10, 2022

Schedule Your Presentation to Thousands of Investors Now

Med, Biotech & Pharma

Emerging Growth Medical, Biotechnology and Pharmaceutical Companies

Biotech Benefits from UpListing – $7.00 Target Price from Think Equity

PetVivo Holdings, Inc. (NASDAQ: PETV), is new to the NASDAQ and has historically been a light trader in terms of volume.  September however marked...

Merck’s Molnupiravir Data Accelerates Tollovir Development

Todos Medical Inc. (OTCMKTS: TOMDF) just announced a major positive update in their development of Tollovir, their COVID-19 antiviral drug. This breaking story uncovered...

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth

Miami, FL--(September 28, 2021) – EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging...

CLS Holdings, (OTCQB: CLSH) FY 2021 $19 Million – 60% Growth – August Alone...

CLS Holdings achieved multiple records in fiscal 2021, including its highest revenue month, quarter, and fiscal year. Revenue increased by 61.9% year-over-year, with total revenue of $19,292,087 for the fiscal year. This figure also represents a 128.1% increase over revenue in fiscal year 2019.

Uplisted to NASDAQ Today! Patent Protection and Security in the Healthcare Space

Some of the largest healthcare companies in the world include UnitedHealth Group Inc. (NYSE: UNH), Pfizer Inc. (NYSE: PFE), and Abbvie Inc. (NYSE: ABBV). These companies are currently sitting above or close to their all-time-high.

Coming in Hot: CLS Holdings USA, Inc. (OTCQB: CLSH) Branded Division Sees Continued Category...

City Trees' concentrate category achieved a 153.2% increase in the number of units sold at the retail level in June 2021 compared to June 2020.

Heating Up: CLS Holdings USA (OTCQB: CLSH), Inc. Announces June Results, Increased Margins and...

LAS VEGAS, NV / ACCESSWIRE / July 13, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating...

CytoDyn’s (CYDY) Long-Hauler Trial a Resounding Success: Clear Pathway to Approval This Year

Clinically Significant Data in 18 of 24 SymptomsSeeking Breakthrough Therapy Designation in Long-Haulers and CancerDefinitive timeline for HIV BLA Filing by October 2021Dosing of...

CLS Holdings USA, Inc. (OTCQB: CLSH) Achieves Substantial Year-Over-Year Results for May 2021

LAS VEGAS, NV / ACCESSWIRE / June 15, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), the ''Company'' or ''CLS'', a diversified cannabis company operating...

5 Small-Cap Pharma Stocks to Buy in June

While the COVID-19 pandemic has cast doubt on many investments, pharma stocks have never looked better. The need for novel treatments and therapies is...

Latest News